![](/img/cover-not-exists.png)
PCV19 COMPARATIVE RISK OF HEART FAILURE HOSPITALIZATIONS ASSOCIATED WITH DAPAGLIFLOZIN VS. EMPAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS: A POPULATION-BASED COHORT STUDY
Shao, S.C., Chang, K.C., Chen, Y.H., Chan, Y.Y., Chen, H.Y., Lai, E.C.C.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.744
Date:
November, 2019
File:
PDF, 660 KB
english, 2019